Dana-Farber Cancer Institute Presents at ASCO22 (IMAGE)

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute Presents at ASCO22

Caption

Several phase 3 studies conducted by researchers from Dana-Farber Cancer Institute show promising results for patients with multiple myeloma and breast cancer. The results of these studies, along with dozens of others led by Dana-Farber researchers, will be presented at the 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO).

Credit

Dana-Farber Cancer Institute

Usage Restrictions

Please courtesy Dana-Farber Cancer Institute

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.